P30274 (CCNA2_BOVIN) Bos taurus (Bovine)
Cyclin-A2 UniProtKBInterProSTRINGInteractive Modelling
430 aa; Sequence (Fasta) ;
4 identical sequences: Bos indicus: A0A6P5BWT7; Bos mutus: A0A6B0RXY5; Bos indicus x Bos taurus: A0A4W2H7M6; Bos mutus grunniens: A0A8B9WPX6
Available Structures
42 Experimental Structures
Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
---|---|---|---|---|---|---|
Structure of phosphorylated Thr160 CDK2/cyclin A in complex with the inhibitor roscovitine |
Heteromer P24941; | 100 | 1×RRC; 1×SGM; | |||
CDK2/CyclinA in complex with AZD5438 |
Heteromer P24941; | 100 | 1×FB8; | |||
Structure of phosphorylated Thr160 CDK2/cyclin A in complex with the inhibitor meriolin 3 |
Heteromer P24941; | 100 | 1×MFR; 1×MG; 2×SGM; | |||
Structure of phosphorylated Thr160 CDK2/cyclin A in complex with the inhibitor variolin B |
Heteromer P24941; | 100 | 1×VAR; 1×MG; 2×SGM; | |||
CDk2/cyclinA in complex with DRB |
Heteromer P24941; | 100 | 1×RFZ; 3×FMT; 1×SGM; | |||
Structure of phosphorylated Thr160 CDK2/cyclin A in complex with the inhibitor meriolin 5 |
Heteromer P24941; | 100 | 1×MHR; 1×MG; | |||
Structure of Thr 160 phosphorylated CDK2/cyclin A in complex with the inhibitor N-&-N1 |
Heteromer P24941; | 100 | 1×NNN; 1×SGM; | |||
Structure of phosphorylated Thr160 CDK2/cyclin A in complex with the inhibitor CR8 |
Heteromer P24941; | 100 | 1×RC8; | |||
CDK2/CyclinA in complex with SU9516 |
Heteromer P24941; | 100 | 1×SU9; | |||
CDK2-cyclin A in complex with FragLite 5 |
Heteromer P24941; | 100 | 3×IIS; | |||
CDK2-cyclin A in complex with FragLite 6 |
Heteromer P24941; | 100 | 2×HGQ; | |||
CDK2-cyclin A in complex with FragLite 31 |
Heteromer P24941; | 100 | 6×HHT; | |||
CDK2-cyclin A in complex with FragLite 17 |
Heteromer P24941; | 100 | 3×A1H6Y; | |||
CDK2-cyclin A in complex with FragLite 24 |
Heteromer P24941; | 100 | 6×IT4; | |||
CDK2-cyclin A in complex with FragLite 18 |
Heteromer P24941; | 100 | 7×IJF; | |||
CDK2-cyclin A in complex with FragLite 26 |
Heteromer P24941; | 100 | 2×UUV; | |||
CDK2-cyclin A in complex with FragLite 29 |
Heteromer P24941; | 100 | 4×V3U; | |||
CDK2-cyclin A in complex with FragLite 28 |
Heteromer P24941; | 100 | 2×UUS; | |||
CDK2-cyclin A in complex with FragLite 12 |
Heteromer P24941; | 100 | 2×IJL; | |||
CDK2-cyclin A in complex with FragLite 16 |
Heteromer P24941; | 100 | 3×HH8; | |||
CDK2-cyclin A in complex with FragLite 27 |
Heteromer P24941; | 100 | 3×W3A; | |||
CDK2-cyclin A in complex with FragLite 20 |
Heteromer P24941; | 100 | 1×IJU; | |||
CDK2-cyclin A in complex with FragLite 30 |
Heteromer P24941; | 100 | 5×W3D; | |||
CDK2-cyclin A in complex with FragLite 14 |
Heteromer P24941; | 100 | 1×HGW; | |||
CDK2-cyclin A in complex with FragLite 22 |
Heteromer P24941; | 100 | 5×UUG; | |||
CDK2-cyclin A in complex with FragLite 1 |
Heteromer P24941; | 100 | 8×BYZ; | |||
Structure of Thr 160 phosphorylated CDK2/cyclin A in complex with the inhibitor NU6271 |
Heteromer P24941; | 99.62 | 1×NU5; | |||
CDK2/CyclinA in complex with Flavopiridol |
Heteromer P24941; | 100 | 1×F9Z; | |||
CDK2-cyclin A in complex with FragLite 8 |
Heteromer P24941; | 100 | 2×T5G; | |||
CDK2-cyclin A in complex with FragLite 7 |
Heteromer P24941; | 100 | 4×HHQ; | |||
CDK2-cyclin A in complex with FragLite 9 |
Heteromer P24941; | 100 | 2×A1H6X; | |||
CDK2/CyclinA in complex with CGP74514A |
Heteromer P24941; | 100 | 1×23D; | |||
CDK2-cyclin A in complex with FragLite 2 |
Heteromer P24941; | 100 | 4×PYZ; 1×EPE; | |||
Cryo-EM structure of CDK2-cyclin A in complex with CDC25A |
Heteromer P24941; P30304; | 100 | ||||
CDK2-cyclin A in complex with FragLite 10 |
Heteromer P24941; | 100 | 6×1P8; | |||
CDK2-cyclin A in complex with FragLite 11 |
Heteromer P24941; | 100 | 3×IJX; | |||
CDK2-cyclin A in complex with FragLite 3 |
Heteromer P24941; | 100 | 1×7ZX; | |||
Structure of CDK2 in complex with cyclin A and a 2-amino-4-heteroaryl- pyrimidine inhibitor |
Heteromer P24941; | 96.9 | 1×T6Q; 2×SGM; 1×SO4; | |||
CDK2-cyclin A in complex with FragLite 4 |
Heteromer P24941; | 100 | 3×HEW; | |||
Structure of CDK2/cyclin A in complex with CAN508 |
Heteromer P24941; | 100 | 1×F18; | |||
Structure of CDK2 in complex with cyclin A and a 2-amino-4-heteroaryl- pyrimidine inhibitor |
Heteromer P24941; | 97.24 | 1×TJF; | |||
BOVINE CYCLIN A3 | monomer | 99.6 | ||||
1 SWISS-MODEL model
Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
---|---|---|---|---|---|---|
8bya.1.B | monomer | 0.79 | 90.47 | |||